Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial

Match Group (NASDAQ:MTCH) Posts Earnings Results, Beats Expectations By $0.04 EPS

Match Group (NASDAQ:MTCH - Get Free Report) issued its earnings results on Tuesday. The technology company reported $0.44 EPS for the quarter, topping the consensus estimate of $0.40 by $0.04, Briefing.com reports. Match Group had a negative return on equity of 313.95% and a net margin of 19.36%. The company had revenue of $860.00 million during the quarter, compared to the consensus estimate of $855.77 million. During the same period in the previous year, the company posted $0.42 EPS. The firm's revenue for the quarter was up 9.3% compared to the same quarter last year.

Match Group Trading Down 5.4 %

Match Group stock traded down $1.69 during trading hours on Wednesday, reaching $29.82. 20,553,516 shares of the stock were exchanged, compared to its average volume of 5,801,081. The company has a market cap of $7.99 billion, a P/E ratio of 13.08, a price-to-earnings-growth ratio of 0.51 and a beta of 1.43. Match Group has a twelve month low of $27.66 and a twelve month high of $49.24. The stock has a 50 day moving average of $33.77 and a two-hundred day moving average of $34.34.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Morgan Stanley cut shares of Match Group from an "overweight" rating to an "equal weight" rating and reduced their price objective for the stock from $53.00 to $37.00 in a research report on Thursday, April 18th. KeyCorp decreased their price target on shares of Match Group from $50.00 to $46.00 and set an "overweight" rating on the stock in a research note on Monday. Raymond James initiated coverage on shares of Match Group in a research report on Thursday, April 4th. They set a "market perform" rating for the company. Piper Sandler reaffirmed an "overweight" rating and issued a $45.00 target price on shares of Match Group in a research report on Wednesday, March 27th. Finally, UBS Group increased their target price on Match Group from $35.00 to $38.00 and gave the stock a "neutral" rating in a research note on Friday, January 26th. Eight equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to data from MarketBeat, Match Group currently has a consensus rating of "Moderate Buy" and a consensus target price of $42.82.


View Our Latest Report on Match Group

Match Group Company Profile

(Get Free Report)

Match Group, Inc engages in the provision of dating products. Its portfolio of brands includes Tinder, Hinge, Match, Meetic, OkCupid, Pairs, Plenty Of Fish, Azar, BLK, and Hakuna, as well as a various other brands, each built to increase users' likelihood of connecting with others. Its services are available in over 40 languages to users worldwide.

Featured Stories

Earnings History for Match Group (NASDAQ:MTCH)

Should you invest $1,000 in Match Group right now?

Before you consider Match Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Match Group wasn't on the list.

While Match Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Featured Articles and Offers

Biotech Boom: Stocks Skyrocketing & What's Next

Biotech Boom: Stocks Skyrocketing & What's Next

Dive into biotech's latest trends with Dylan Jovine: weight loss breakthroughs, smart chemo innovations, and expert stock evaluation tips.

Search Headlines: